New Myeloma UK Chief Executive appointed

Myeloma UK news // 12th April 2022

Myeloma UK is delighted to share the news that Sophie Castell has been appointed as Chief Executive.

Sophie, who was formerly Relationships Director at the Royal National Institute of Blind People, will take over from Laura Kerby and join the charity in May. Sophie said:

“I am hugely excited to be joining Myeloma UK as its new CEO and it is a privilege to be taking up the role in the organisation’s 25th anniversary year. I am passionate about supporting people to live well and building hopeful futures.

“Myeloma UK plays a vital role in supporting everyone affected by myeloma. I am very much looking forward to meeting patients, our partners and supporters over the next few months and working together with the whole Myeloma UK community to address the challenges of living with the condition and supporting research to discover new treatments.”

Since gaining a PhD in Biochemistry and an MBA, Sophie’s career has spanned executive, interim and consulting roles across the commercial, voluntary and public sectors in both the UK and USA. She has worked with a diverse range of organisations including Coca-Cola, Unilever Ventures, the Canal & River Trust, Save the Children and the NHS.

She co-founded the Enfield Branch of the National Autistic Society before joining the charity’s Board of Trustees, where she now serves on the Plans and Resources Committee and chairs the Brand and Commercial Development Committee.

Simon Linnett, Chairman of Myeloma UK’s Board of Trustees said:

“We are delighted to welcome Sophie to the charity where she will build on Myeloma UK’s ambition to make myeloma history. Sophie brings 20 years of committed charitable service and a comprehensive understanding of the third sector to Myeloma UK. Her commitment to putting the communities that charities serve at the very heart of decision-making and delivery is a natural fit for both the charity and our myeloma community.”